» Authors » Lili Duse

Lili Duse

Explore the profile of Lili Duse including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 229
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abu Dayyih A, Alawak M, Ayoub A, Amin M, Dayyih W, Engelhardt K, et al.
Int J Pharm . 2021 Oct; 609:121195. PMID: 34673168
The potent photodynamic properties of Hypericin (Hyp) elicit a range of light-dose-dependent anti-tumor activities. However, its low water solubility hampers its broad application. Therefore, the administration of Hyp into biological...
2.
Lehmann J, Agel M, Engelhardt K, Pinnapireddy S, Agel S, Duse L, et al.
Pharmaceutics . 2021 Aug; 13(8). PMID: 34452205
Lung cancer is one of the most common causes for a high number of cancer related mortalities worldwide. Therefore, it is important to improve the therapy by finding new targets...
3.
Alawak M, Abu Dayyih A, Mahmoud G, Tariq I, Duse L, Goergen N, et al.
Eur J Pharm Biopharm . 2020 Dec; 158:390-400. PMID: 33338603
Metastatic breast cancer is one of the most common causes of cancer-related death in women worldwide. The transmembrane metalloprotease-disintegrin (ADAM8) protein is highly overexpressed in triple-negative breast cancer (TNBC) cells...
4.
Ambreen G, Duse L, Tariq I, Ali U, Ali S, Pinnapireddy S, et al.
Cancers (Basel) . 2020 Nov; 12(11). PMID: 33167593
Photodynamic therapy (PDT) is a minimally invasive therapeutic approach used in the treatment of various medical conditions and cancerous diseases, involving light, a photosensitizing substance, and oxygen. Curcumin, a naturally...
5.
Alawak M, Mahmoud G, Abu Dayyih A, Duse L, Pinnapireddy S, Engelhardt K, et al.
Mater Sci Eng C Mater Biol Appl . 2020 Jul; 115:111116. PMID: 32600717
To limit the massive cytotoxicity of chemotherapeutic agents, it is desirable to establish an appropriate subtle blend of formulation design based on a dual-responsive strategy. In this study, a combined...
6.
Ali S, Amin M, Ali M, Tariq I, Pinnapireddy S, Duse L, et al.
Eur J Pharm Biopharm . 2020 Mar; 150:50-65. PMID: 32151728
5,10,15,20-Tetrakis(3-hydroxyphenyl)chlorin (mTHPC; temoporfin) is one of the most potent second-generation photosensitizers available today for the treatment of a variety of clinical disorders and has a unique capability of being activated...
7.
Ali M, Tariq I, Ali S, Amin M, Engelhardt K, Pinnapireddy S, et al.
Int J Pharm . 2019 Dec; 575:118961. PMID: 31846731
Surface modification of nanoparticles with aptamer is gaining popularity lately due to its selective targeting and low immunogenicity. In this study, sorafenib tosylate (SFB) was loaded in biodegradable PLGA nanoparticles...
8.
Plenagl N, Seitz B, Duse L, Pinnapireddy S, Jedelska J, Brussler J, et al.
Int J Pharm . 2019 Sep; 570:118666. PMID: 31494239
The naturally occurring anthraquinone derivative hypericin is a highly potent photosensitiser. Several in vitro studies show high phototoxicity of the pigment towards gram-positive bacteria. Nevertheless, the highly lipophilic nature and...
9.
Vogeling H, Plenagl N, Seitz B, Duse L, Pinnapireddy S, Dayyoub E, et al.
Mater Sci Eng C Mater Biol Appl . 2019 Jul; 103:109749. PMID: 31349520
Catheter related infections are causing one third of all blood stream infections. The mortality of those infections is very high and the gold standard for catheter related blood stream infections...
10.
Duse L, Agel M, Pinnapireddy S, Schafer J, Selo M, Ehrhardt C, et al.
Pharmaceutics . 2019 Jun; 11(6). PMID: 31208085
Accumulation of photosensitisers in photodynamic therapy in healthy tissues is often the cause of unwanted side effects. Using nanoparticles, improved bioavailability and site-specific drug uptake can be achieved. In this...